| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(61)90304-X |
| P698 | PubMed publication ID | 13790531 |
| P2093 | author name string | H C JONES | |
| J SWINNEY | |||
| P2860 | cites work | Absorption of water, urea, glucose and electrolytes through the human bladder | Q73104004 |
| Further Studies on Absorption Through the Human Bladder | Q78639855 | ||
| Chemotherapy of Solid Tumors with Triethylene Thiophosphoramide | Q78646198 | ||
| P433 | issue | 7203 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 615-618 | |
| P577 | publication date | 1961-09-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Thiotepa in the treatment of tumours of the bladder | |
| P478 | volume | 2 |
| Q39672312 | A Longitudinal Study of Patients with Superficial Bladder Carcinoma Successfully Treated with Weekly Intravesical Thio-TEPA |
| Q30544543 | A chemist's view of cancer prevention |
| Q46474564 | A note from history: Landmarks in history of cancer, Part 6. |
| Q67552734 | A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT |
| Q44300205 | Absorption Studies on Intraluminal Thio-Tepa for Topical Cytostatic Treatment of Low-Stage Bladder Tumors |
| Q39673974 | Adjuvant Therapy of T1 Bladder Carcinoma: Preliminary Results of an EORTC Randomized Study |
| Q33851141 | An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy |
| Q37043486 | BCG and the Treatment of Superficial Bladder Cancer |
| Q39915463 | Bladder Carcinoma |
| Q70152782 | Bladder cancer |
| Q46780903 | Characterization of cellular infiltrates in the rat urinary bladder following BCG and thiotepa intravesical therapy |
| Q33462155 | Chemotherapy for bladder cancer |
| Q38679784 | Chemotherapy in the management of bladder tumours |
| Q41360899 | Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer |
| Q69419848 | Current status of intravesical chemotherapy trials in the EORTC Urological Group. An overview |
| Q67801430 | Denudation of the urinary bladder mucosa in the cat by formaldehyde |
| Q69978827 | Detecting mitomycin C in human plasma during intravesical therapy |
| Q69720410 | Difficulties in evaluating urinary specimens after local mitomycin therapy of bladder cancer |
| Q42253981 | Early adjuvant adriamycin in superficial bladder carcinoma |
| Q24657363 | Early onset life-threatening myelosuppression after low dose of intravesical thiotepa |
| Q69778979 | Effects of hyperthermia on bladder cancer |
| Q41429887 | Epodyl® Treatment of Bladder Tumours |
| Q79059068 | Estimation of Thiotepa in Urine |
| Q68947754 | Gas-liquid chromatographic analysis of N,N',N''-triethylene thiophosphoramide and N,N',N''-triethylene phosphoramide in biological samples |
| Q69267097 | High-performance liquid chromatographic analysis of N,N',N"-triethylenethiophosphoramide in human plasma |
| Q93825307 | Intracavitary chemotherapy for multiple non-invasive bladder tumours |
| Q39624455 | Intravesical Thio-tepa in the Immediate Postoperative Period in Patients with Recurrent Transitional Cell Carcinoma of the Bladder |
| Q44278444 | Intravesical adriamycin chemotherapy in bladder cancer |
| Q69419845 | Intravesical chemotherapy |
| Q70473094 | Intravesical chemotherapy for superficial bladder cancer |
| Q40108448 | Intravesical chemotherapy in the United States. An overview. |
| Q34708823 | Intravesical instillation of adriamycin in treatment of bladder cancer |
| Q73755473 | Intravesical therapy of superficial bladder cancer |
| Q39750366 | Invasive bladder cancer--possible future treatment considerations |
| Q48858566 | Landmarks in non-muscle-invasive bladder cancer |
| Q44978079 | Late results of cystectomy in carcinoma of the urinary bladder |
| Q39677410 | Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder |
| Q41488209 | Long-term Follow-up in Patients with Superficial Bladder Tumours Treated with Intravesical Epodyl |
| Q51423986 | Mechanisms and kinetics of thiotepa and tepa hydrolysis: DFT study. |
| Q52681694 | Methodologies for quantifying the results of intravesical chemotherapy of superficial tumors of the bladder. |
| Q71097641 | Minimization of inflammation in the treatment of bladder tumors by intravesical instillation of adriamycin |
| Q45039683 | Mitomycin C Bladder Instillation Therapy for Bladder Tumors |
| Q39005578 | Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guérin. |
| Q52431476 | On the search for new anticancer drugs 14: the plasma pharmacokinetics and tissue distribution of spin-labeled thio-TEPA (SL-O-TT). |
| Q67298194 | Partial Cystectomy in the Treatment of Transitional Cell Carcinoma of the Bladder |
| Q70095028 | Pre-cancerous changes in bladder epithelium |
| Q70362728 | Prophylactic treatment for superficial bladder cancer following transurethral resection |
| Q36095941 | Rapid absorption from the urinary bladder of a series of n-alkyl carbamates: a route for the recirculation of drugs |
| Q86507878 | Side effects of perioperative intravesical treatment and treatment strategies for these side effects |
| Q72398256 | Superficial bladder cancer |
| Q45119627 | The Association of Urothelial Atypism with Neoplasia: Its Importance in Treatment and Prognosis |
| Q41356291 | The Effect of Intravesical Thio-tepa on Normal and Tumor Urothelium |
| Q26738516 | The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer |
| Q88230171 | The Management of Superficial Bladder Cancer |
| Q34699795 | The Management of Superficial Bladder Tumours with Intravesical Epody1 |
| Q69375650 | The Role of Cystography in Thio-Tepa Toxicity |
| Q35058173 | The chemotherapy of urologic cancer |
| Q39869499 | The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours |
| Q53509124 | The safety and efficacy of different doses of bacillus Calmette Guérin in superficial bladder transitional cell carcinoma. |
| Q67653080 | ThioTEPA pharmacokinetics during intravesical chemotherapy and the influence of Tween 80 |
| Q37198049 | Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer |
| Q66913842 | Treatment of Multiple Superficial Papillary Tumors of the Bladder by Intracavitary Yttrium-90 |
| Q35645524 | Treatment of superficial bladder cancer |
| Q39326123 | Update in cancer chemotherapy: genitourinary tract cancer, Part 2: Wilms' tumor and bladder cancer |
| Q54437687 | Verapamil enhanced in vitro chemosensitivity of a murine bladder carcinoma, FCB. |
Search more.